[Peptide receptor radionuclide therapy for patients with somatostatin receptor expressing tumours. German Guideline (S1)] (original) (raw)

Nuklearmedizin. Nuclear medicine, 2015

Abstract

This document describes the guideline for peptide receptor radionuclide therapy (PRRT) published by the German Society of Nuclear Medicine (DGN) and accepted by the Association of the Scientific Medical Societies in Germany (AWMF) to be included in the official AWMF Guideline Registry. These recommendations are a prerequisite for the quality management in the treatment of patients with somatostatin receptor expressing tumours using PRRT. They are aimed at guiding nuclear medicine specialists in selecting likely candidates to receive PRRT and to deliver the treatment in a safe and effective manner. The recommendations are based on an interdisciplinary consensus. The document contains background information and definitions and covers the rationale, indications and contraindications for PRRT. Essential topics are the requirements for institutions performing the therapy, e. g. presence of an expert for medical physics, intense cooperation with all colleagues involved in the treatment of...

T. Poeppel hasn't uploaded this paper.

Let T. know you want this paper to be uploaded.

Ask for this paper to be uploaded.